EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Disruption of Ca 2+ /calmodulin: KSR1 interaction lowers ERK activation

Louise Thines, Hyunbum Jang, Zhigang Li, Samar Sayedyahossein, Ryan Maloney, Ruth Nussinov iD, David B Sacks iD

Protein Science · 2024

DOI: 10.1002/pro.4982 ↗

At a glance

Journal article in Protein Science, 2024. Written by Louise Thines and 6 co-authors. Institution: Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland, USA. Major MEDLINE topics: Calmodulin, Calcium Signaling. Cited 5 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NCI NIH HHS, NIH HHS, National Cancer Institute.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

KSR1, a key scaffold protein for the MAPK pathway, facilitates ERK activation upon growth factor stimulation. We recently demonstrated that KSR1 binds the Ca 2+ ‐binding protein calmodulin (CaM), thereby providing an intersection between KSR1‐mediated and Ca 2+ signaling. In this study, we set out to generate a KSR1 point mutant with reduced Ca 2+ /CaM binding in order to unravel the functional implications of their interaction. To do so, we solved the structural determinants of complex formation. Using purified fragments of KSR1, we showed that Ca 2+ /CaM binds to the CA3 domain of KSR1. We then used in silico molecular modeling to predict contact residues for binding. This approach identified two possible modes of interaction: (1) binding of extended Ca 2+ /CaM to a globular conformation of KSR1‐CA3 via electrostatic interactions or (2) binding of collapsed Ca 2+ /CaM to α‐helical KSR1‐CA3 via hydrophobic interactions. Experimentally, site‐directed mutagenesis of the predicted contact residues for the two binding models favored that where collapsed Ca 2+ /CaM binds to the α‐helical conformation of KSR1‐CA3. Importantly, replacing KSR1‐Phe 355 with Asp reduces Ca 2+ /CaM binding by 76%. The KSR1‐F 355 D mutation also significantly impairs the ability of EGF to activate ERK, which reveals that Ca 2+ /CaM binding promotes KSR1‐mediated MAPK signaling. This work, by uncovering structural insight into the binding of KSR1 to Ca 2+ /CaM, identifies a KSR1 single‐point mutant as a bioreagent to selectively study the crosstalk between Ca 2+ and KSR1‐mediated signaling.

Subjects

MeSH terms (MEDLINE)

CalmodulinCalcium SignalingProtein BindingMutationMutagenesis, Site-DirectedCalcium

Author keywords

CA3ERKKSR1MAPKcalciumcalmodulinmolecular dynamicssignaling

Substances

CalmodulinCalcium

Authors and institutions

  • Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland, USA.
  • Computational Structural Biology Section, Frederick National Laboratory for Cancer Research in the Cancer Innovation Laboratory, National Cancer Institute, Frederick, Maryland, USA.
  • Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

ORCID profiles: Ruth Nussinov, David B Sacks

Funding

  • NCI NIH HHS
  • NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Cite

APA

Thines, L., Jang, H., Li, Z., Sayedyahossein, S., Maloney, R., Nussinov, R., & Sacks, D. B. (2024). Disruption of Ca 2+ /calmodulin: KSR1 interaction lowers ERK activation. Protein Science. https://doi.org/10.1002/pro.4982

Vancouver

Thines L, Jang H, Li Z, Sayedyahossein S, Maloney R, Nussinov R, et al. Disruption of Ca 2+ /calmodulin: KSR1 interaction lowers ERK activation. Protein Science. 2024. doi:10.1002/pro.4982

BibTeX
@article{Thines2024,
  author = {Thines, Louise and Jang, Hyunbum and Li, Zhigang and Sayedyahossein, Samar and Maloney, Ryan and Nussinov, Ruth and Sacks, David B},
  title = {Disruption of Ca 2+ /calmodulin: KSR1 interaction lowers ERK activation},
  journal = {Protein Science},
  year = {2024},
  doi = {10.1002/pro.4982}
}
Start for free →